LIF, a Novel Myokine, Protects Against Amyloid-Beta-Induced Neurotoxicity via Akt-Mediated Autophagy Signaling in Hippocampal Cells

Hye Jeong Lee, Jung Ok Lee, Yong Woo Lee, Shin Ae Kim, Il Hyeok Seo, Jeong Ah Han, Min Ju Kang, Su Jin Kim, Yun Ho Cho, Joong Jean Park, Jongil Choi, Sun-Hwa Park, Hyeon Soo Kim

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

BACKGROUND: Leukemia inhibitory factor, a novel myokine, is known to be associated with neural function, but the underlying molecular mechanism remains unclear. METHODS: HT-22 mouse hippocampal cells, primary hippocampal cells, and Drosophila Alzheimer's disease model were used to determine the effect of leukemia inhibitory factor on neurons. Immunoblot analysis and immunofluorescence method were used to analyze biological mechanism. RESULTS: Leukemia inhibitory factor increased Akt phosphorylation in a phosphoinositide-3-kinase-dependent manner in hippocampal cells. Leukemia inhibitory factor also increased the phosphorylation of the mammalian target of rapamycin and the downstream S6K. Leukemia inhibitory factor stimulated the phosphorylation of signal transducer and activator of transcription via extracellular signal-regulated kinases. Leukemia inhibitory factor increased c-fos expression through both Akt and extracellular signal-regulated kinases. Leukemia inhibitory factor blocked amyloid β-induced neural viability suppression and inhibited amyloid β-induced glucose uptake impairment through the block of amyloid β-mediated insulin receptor downregulation. Leukemia inhibitory factor blocked amyloid β-mediated induction of the autophagy marker, microtubule-associated protein 1A/1B-light chain 3. Additionally, in primary prepared hippocampal cells, leukemia inhibitory factor stimulated Akt and extracellular signal-regulated kinase, demonstrating that leukemia inhibitory factor has physiological relevance in vivo. Suppression of the autophagy marker, light chain 3II, by leukemia inhibitory factor was observed in a Drosophila model of Alzheimer's disease. CONCLUSIONS: These results demonstrate that leukemia inhibitory factor protects against amyloid β-induced neurotoxicity via Akt/extracellular signal-regulated kinase-mediated c-fos induction, and thus suggest that leukemia inhibitory factor is a potential drug for Alzheimer's disease.

Original languageEnglish
Pages (from-to)402-414
Number of pages13
JournalThe international journal of neuropsychopharmacology
Volume22
Issue number6
DOIs
Publication statusPublished - 2019 Jun 3

Fingerprint

Leukemia Inhibitory Factor
Autophagy
Amyloid
Extracellular Signal-Regulated MAP Kinases
Alzheimer Disease
Phosphorylation
Drosophila
Light
1-Phosphatidylinositol 4-Kinase
Insulin Receptor
Sirolimus
Transducers
Fluorescent Antibody Technique

Keywords

  • Akt
  • Alzheimer’s disease
  • autophagy
  • LIF
  • mTOR
  • myokine

ASJC Scopus subject areas

  • Pharmacology
  • Psychiatry and Mental health
  • Pharmacology (medical)

Cite this

LIF, a Novel Myokine, Protects Against Amyloid-Beta-Induced Neurotoxicity via Akt-Mediated Autophagy Signaling in Hippocampal Cells. / Lee, Hye Jeong; Lee, Jung Ok; Lee, Yong Woo; Kim, Shin Ae; Seo, Il Hyeok; Han, Jeong Ah; Kang, Min Ju; Kim, Su Jin; Cho, Yun Ho; Park, Joong Jean; Choi, Jongil; Park, Sun-Hwa; Kim, Hyeon Soo.

In: The international journal of neuropsychopharmacology, Vol. 22, No. 6, 03.06.2019, p. 402-414.

Research output: Contribution to journalArticle

Lee, Hye Jeong ; Lee, Jung Ok ; Lee, Yong Woo ; Kim, Shin Ae ; Seo, Il Hyeok ; Han, Jeong Ah ; Kang, Min Ju ; Kim, Su Jin ; Cho, Yun Ho ; Park, Joong Jean ; Choi, Jongil ; Park, Sun-Hwa ; Kim, Hyeon Soo. / LIF, a Novel Myokine, Protects Against Amyloid-Beta-Induced Neurotoxicity via Akt-Mediated Autophagy Signaling in Hippocampal Cells. In: The international journal of neuropsychopharmacology. 2019 ; Vol. 22, No. 6. pp. 402-414.
@article{d01c8d63e9b24138b4811cca40f10968,
title = "LIF, a Novel Myokine, Protects Against Amyloid-Beta-Induced Neurotoxicity via Akt-Mediated Autophagy Signaling in Hippocampal Cells",
abstract = "BACKGROUND: Leukemia inhibitory factor, a novel myokine, is known to be associated with neural function, but the underlying molecular mechanism remains unclear. METHODS: HT-22 mouse hippocampal cells, primary hippocampal cells, and Drosophila Alzheimer's disease model were used to determine the effect of leukemia inhibitory factor on neurons. Immunoblot analysis and immunofluorescence method were used to analyze biological mechanism. RESULTS: Leukemia inhibitory factor increased Akt phosphorylation in a phosphoinositide-3-kinase-dependent manner in hippocampal cells. Leukemia inhibitory factor also increased the phosphorylation of the mammalian target of rapamycin and the downstream S6K. Leukemia inhibitory factor stimulated the phosphorylation of signal transducer and activator of transcription via extracellular signal-regulated kinases. Leukemia inhibitory factor increased c-fos expression through both Akt and extracellular signal-regulated kinases. Leukemia inhibitory factor blocked amyloid β-induced neural viability suppression and inhibited amyloid β-induced glucose uptake impairment through the block of amyloid β-mediated insulin receptor downregulation. Leukemia inhibitory factor blocked amyloid β-mediated induction of the autophagy marker, microtubule-associated protein 1A/1B-light chain 3. Additionally, in primary prepared hippocampal cells, leukemia inhibitory factor stimulated Akt and extracellular signal-regulated kinase, demonstrating that leukemia inhibitory factor has physiological relevance in vivo. Suppression of the autophagy marker, light chain 3II, by leukemia inhibitory factor was observed in a Drosophila model of Alzheimer's disease. CONCLUSIONS: These results demonstrate that leukemia inhibitory factor protects against amyloid β-induced neurotoxicity via Akt/extracellular signal-regulated kinase-mediated c-fos induction, and thus suggest that leukemia inhibitory factor is a potential drug for Alzheimer's disease.",
keywords = "Akt, Alzheimer’s disease, autophagy, LIF, mTOR, myokine",
author = "Lee, {Hye Jeong} and Lee, {Jung Ok} and Lee, {Yong Woo} and Kim, {Shin Ae} and Seo, {Il Hyeok} and Han, {Jeong Ah} and Kang, {Min Ju} and Kim, {Su Jin} and Cho, {Yun Ho} and Park, {Joong Jean} and Jongil Choi and Sun-Hwa Park and Kim, {Hyeon Soo}",
year = "2019",
month = "6",
day = "3",
doi = "10.1093/ijnp/pyz016",
language = "English",
volume = "22",
pages = "402--414",
journal = "International Journal of Neuropsychopharmacology",
issn = "1461-1457",
publisher = "Cambridge University Press",
number = "6",

}

TY - JOUR

T1 - LIF, a Novel Myokine, Protects Against Amyloid-Beta-Induced Neurotoxicity via Akt-Mediated Autophagy Signaling in Hippocampal Cells

AU - Lee, Hye Jeong

AU - Lee, Jung Ok

AU - Lee, Yong Woo

AU - Kim, Shin Ae

AU - Seo, Il Hyeok

AU - Han, Jeong Ah

AU - Kang, Min Ju

AU - Kim, Su Jin

AU - Cho, Yun Ho

AU - Park, Joong Jean

AU - Choi, Jongil

AU - Park, Sun-Hwa

AU - Kim, Hyeon Soo

PY - 2019/6/3

Y1 - 2019/6/3

N2 - BACKGROUND: Leukemia inhibitory factor, a novel myokine, is known to be associated with neural function, but the underlying molecular mechanism remains unclear. METHODS: HT-22 mouse hippocampal cells, primary hippocampal cells, and Drosophila Alzheimer's disease model were used to determine the effect of leukemia inhibitory factor on neurons. Immunoblot analysis and immunofluorescence method were used to analyze biological mechanism. RESULTS: Leukemia inhibitory factor increased Akt phosphorylation in a phosphoinositide-3-kinase-dependent manner in hippocampal cells. Leukemia inhibitory factor also increased the phosphorylation of the mammalian target of rapamycin and the downstream S6K. Leukemia inhibitory factor stimulated the phosphorylation of signal transducer and activator of transcription via extracellular signal-regulated kinases. Leukemia inhibitory factor increased c-fos expression through both Akt and extracellular signal-regulated kinases. Leukemia inhibitory factor blocked amyloid β-induced neural viability suppression and inhibited amyloid β-induced glucose uptake impairment through the block of amyloid β-mediated insulin receptor downregulation. Leukemia inhibitory factor blocked amyloid β-mediated induction of the autophagy marker, microtubule-associated protein 1A/1B-light chain 3. Additionally, in primary prepared hippocampal cells, leukemia inhibitory factor stimulated Akt and extracellular signal-regulated kinase, demonstrating that leukemia inhibitory factor has physiological relevance in vivo. Suppression of the autophagy marker, light chain 3II, by leukemia inhibitory factor was observed in a Drosophila model of Alzheimer's disease. CONCLUSIONS: These results demonstrate that leukemia inhibitory factor protects against amyloid β-induced neurotoxicity via Akt/extracellular signal-regulated kinase-mediated c-fos induction, and thus suggest that leukemia inhibitory factor is a potential drug for Alzheimer's disease.

AB - BACKGROUND: Leukemia inhibitory factor, a novel myokine, is known to be associated with neural function, but the underlying molecular mechanism remains unclear. METHODS: HT-22 mouse hippocampal cells, primary hippocampal cells, and Drosophila Alzheimer's disease model were used to determine the effect of leukemia inhibitory factor on neurons. Immunoblot analysis and immunofluorescence method were used to analyze biological mechanism. RESULTS: Leukemia inhibitory factor increased Akt phosphorylation in a phosphoinositide-3-kinase-dependent manner in hippocampal cells. Leukemia inhibitory factor also increased the phosphorylation of the mammalian target of rapamycin and the downstream S6K. Leukemia inhibitory factor stimulated the phosphorylation of signal transducer and activator of transcription via extracellular signal-regulated kinases. Leukemia inhibitory factor increased c-fos expression through both Akt and extracellular signal-regulated kinases. Leukemia inhibitory factor blocked amyloid β-induced neural viability suppression and inhibited amyloid β-induced glucose uptake impairment through the block of amyloid β-mediated insulin receptor downregulation. Leukemia inhibitory factor blocked amyloid β-mediated induction of the autophagy marker, microtubule-associated protein 1A/1B-light chain 3. Additionally, in primary prepared hippocampal cells, leukemia inhibitory factor stimulated Akt and extracellular signal-regulated kinase, demonstrating that leukemia inhibitory factor has physiological relevance in vivo. Suppression of the autophagy marker, light chain 3II, by leukemia inhibitory factor was observed in a Drosophila model of Alzheimer's disease. CONCLUSIONS: These results demonstrate that leukemia inhibitory factor protects against amyloid β-induced neurotoxicity via Akt/extracellular signal-regulated kinase-mediated c-fos induction, and thus suggest that leukemia inhibitory factor is a potential drug for Alzheimer's disease.

KW - Akt

KW - Alzheimer’s disease

KW - autophagy

KW - LIF

KW - mTOR

KW - myokine

UR - http://www.scopus.com/inward/record.url?scp=85067087193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067087193&partnerID=8YFLogxK

U2 - 10.1093/ijnp/pyz016

DO - 10.1093/ijnp/pyz016

M3 - Article

C2 - 31125414

AN - SCOPUS:85067087193

VL - 22

SP - 402

EP - 414

JO - International Journal of Neuropsychopharmacology

JF - International Journal of Neuropsychopharmacology

SN - 1461-1457

IS - 6

ER -